Neuroone Medical Technologies (NMTC) EBITDA Margin (2010 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly EBITDA Margin came in at 128.74% in Q1 2026, up 6455.0% YoY from 1.96% in Q1 2025, and down 118.12% on a QoQ basis from 59.02% in Q4 2025.
Neuroone Medical Technologies (NMTC) EBITDA Margin (2010 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has 13 years of EBITDA Margin data on file, last reported at 128.74% in Q1 2026.
- Quarterly EBITDA Margin rose 6455.0% year-over-year to 128.74% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 80.1% (up 3415.0% YoY) and the FY2025 annual result came in at 46.46%, up 29780.0% from the prior year.
- EBITDA Margin eased to 128.74% in Q1 2026, from 59.02% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 52.26% in Q4 2024 to a low of 8616.29% in Q2 2022.
- A 5-year average of 1454.47% and a median of 346.8% in 2023 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2022 — EBITDA Margin plunged 104696 bps — and 2023, when it soared 805902 bps.
- Tracing NMTC's EBITDA Margin over 5 years: stood at 1557.31% in 2022, then surged by 78 bps to 346.8% in 2023, then soared by 115 bps to 52.26% in 2024, then plunged by 213 bps to 59.02% in 2025, then slumped by 118 bps to 128.74% in 2026.
- The last three EBITDA Margin figures came in at 128.74% (Q1 2026), 59.02% (Q4 2025), and 50.02% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 19.15% |
| 10 | Neuroone Medical Technologies | 19.64 Mn | 17.59 Mn | 1.18 Mn | -122.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -122.87% |
| Mar 31, 2026 | -128.74% |
| Dec 31, 2025 | -59.02% |
| Sep 30, 2025 | -50.02% |
| Jun 30, 2025 | -111.23% |
| Mar 31, 2025 | -193.29% |
| Dec 31, 2024 | 52.26% |
| Sep 30, 2024 | -1,034.48% |
| Jun 30, 2024 | -338.34% |
| Mar 31, 2024 | -209.55% |
| Dec 31, 2023 | -346.80% |
| Sep 30, 2023 | -426.64% |
| Jun 30, 2023 | -557.26% |
| Mar 31, 2023 | -749.91% |
| Dec 31, 2022 | -1,557.31% |
| Sep 30, 2022 | -2,035.52% |
| Jun 30, 2022 | -8,616.29% |
| Mar 31, 2022 | -8,363.79% |
| Dec 31, 2021 | -8,324.42% |
| Sep 30, 2021 | -5,470.30% |